Clinical Trial Update: 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 131I-L19SIP radioimmunotherapy in combination with external beam radiation for patients with multiple brain metastases from solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases From Solid Tumors

Drugs mentioned

• 131I-L19SIP (L19SIP radiopharmaceutical (radioimmunotherapy))

Snippet

Sponsor: Philogen S.p.A. | Conditions: Brain Metastases From Solid Tumors | Phase 2 | Status: COMPLETED